Skip to Main Content

INFORMATION FOR

Latest News

Inhibition of Small RNA in Lung Macrophages May Counter Pulmonary Fibrosis

Researchers at the Yale School of Medicine (YSM) who study idiopathic pulmonary fibrosis, a debilitating and fatal lung disease, designed a molecule that reverses pulmonary fibrosis in a preclinical model of the disease and in cultured human lung tissue. The drug inhibits a microRNA, called miR-33, and protects against fibrosis by improving the metabolic functions of lung macrophages. The results appeared online on January 10, 2023, in JCI Insight.

Read more